Death by a B cell superantigen: In vivo VH-targeted apoptotic supraclonal B cell deletion by a staphylococcal toxin

Journal of Experimental Medicine

Volumn 197, Issue 9, 2003, Pages 1125-1139

  Goodyear, Carl S ^a   Silverman, Gregg J ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Clonal selection; Host immunity; Ig genes; Repertoire; Tolerance

Indexed keywords

B LYMPHOCYTE ANTIGEN; B LYMPHOCYTE RECEPTOR; CASPASE; CD19 ANTIGEN; CD40 LIGAND; COMPLEMENT COMPONENT C3D RECEPTOR; DNA FRAGMENT; FAS ANTIGEN; IMMUNOGLOBULIN HEAVY CHAIN; INTERLEUKIN 4; LYMPHOCYTE RECEPTOR; PROTEIN BCL 2; STAPHYLOCOCCUS ENTEROTOXIN A; STAPHYLOCOCCUS TOXIN; SUPERANTIGEN;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN BINDING; APOPTOSIS; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELL PROTECTION; CELL SELECTION; CLONAL VARIATION; CONTROLLED STUDY; ENZYME ACTIVATION; GENE OVEREXPRESSION; GENE REARRANGEMENT; HOST; IMMUNITY; IMMUNOGLOBULIN GENE; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOLOGICAL TOLERANCE; IMMUNOPHENOTYPING; LYMPH NODE; LYMPHOCYTE PROLIFERATION; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MOUSE; NONHUMAN; PEYER PATCH; PRIORITY JOURNAL; RECEPTOR BINDING; SPLEEN;

ANIMALS; APOPTOSIS; B-LYMPHOCYTES; BASE SEQUENCE; DNA PRIMERS; GENE REARRANGEMENT, B-LYMPHOCYTE; IN SITU NICK-END LABELING; LYMPHOCYTE DEPLETION; MICE; MICE, INBRED C57BL; PHENOTYPE; STAPHYLOCOCCAL TOXOID; SUPERANTIGENS;

EID: 0038558241     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20020552     Document Type: Article

References (66)

1. Silverman, G.J., and C.S. Goodyear. 2002. A model B-cell superantigen and the immunobiology of B lymphocytes. Clin. Immunol. 102:117-134.
2. Graille, M., E.A. Stura, A.L. Corper, B.J. Sutton, M.J. Taussig, J.B. Charbonnier, and G.J. Silverman. 2000. Crystal structure of a Staphylococcus aureus protein A domain complexed with the Fab fragment of a human IgM antibody: structural basis for recognition of B-cell receptors and superantigen activity. Proc. Natl. Acad. Sci. USA. 97:5399-5404.
3. Cary, S.P., J. Lee, R. Wagenknecht, and G.J. Silverman. 2000. Characterization of superantigen-induced clonal deletion with a novel clan III-restricted avian monoclonal antibody: exploiting evolutionary distance to create antibodies specific for a conserved VH region surface. J. Immunol. 164: 4730-4741.
4. Cary, S., M. Krishnan, T.N. Marion, and G.J. Silverman. 1999. The murine clan V(H) III related 7183, J606 and S107 and DNA4 families commonly encode for binding to a bacterial B cell superantigen. Mol. Immunol. 36:769-776.
5. Silverman, G.J., J.V. Nayak, K. Warnatz, S. Cary, H. Tighe, and V.E. Curtiss. 1998. The dual phases of the response to neonatal exposure to a VH family-restricted staphylococcal B-cell superantigen. J. Immunol. 161:5720-5732.
6. Silverman, G.J., S.P. Cary, D.C. Dwyer, L. Luo, R. Wagenknecht, and V.E. Curtiss. 2000. A B cell superantigen-induced persistent "Hole" in the B-1 repertoire. J. Exp. Med. 192:87-98.
7. Silverman, G.J. 2001. Adoptive transfer of a superantigen-induced "hole" in the repertoire of natural IgM-secreting cells. Cell. Immunol. 209:76-80.
8. Feeney, A.J. 1992. Predominance of VH-D-JH junctions occurring at sites of short sequence homology results in limited junctional diversity in neonatal antibodies. J. Immunol. 149: 222-229.
9. Bernardi, P., L. Scorrano, R. Colonna, V. Petronilli, and F. Di Lisa. 1999. Mitochondria and cell death. Mechanistic aspects and methodological issues. Eur. J. Biochem. 264:687-701.
10. Martin-Orozco, E., H. Kobayashi, J. Van Uden, M.D. Nguyen, R.S. Kornbluth, and E. Raz. 1999. Enhancement of antigen-presenting cell surface molecules involved in cognate interactions by immunostimulatory DNA sequences. Int. Immunol. 11:1111-1118.
11. Lane, P., T. Brocker, S. Hubele, E. Padovan, A. Lanzavecchia, and F. McConnell. 1993. Soluble CD40 ligand can replace the normal T cell-derived CD40 ligand signal to B cells in T cell-dependent activation. J. Exp. Med. 177:1209-1213.
12. Kozlowski, L.M., A.M. Soulika, G.J. Silverman, J.D. Lambris, and A.I. Levinson. 1996. Complement activation by a B cell superantigen. J. Immunol. 157:1200-1206.
13. Phee, H., W. Rodgers, and K.M. Coggeshall. 2001. Visualization of negative signaling in B cells by quantitative confocal microscopy. Mol. Cell. Biol. 21:8615-8625.
14. Finkelman, F.D., J.M. Holmes, O.I. Dukhanina, and S.C. Morris. 1995. Cross-linking of membrane immunoglobulin D, in the absence of T cell help, kills mature B cells in vivo. J. Exp. Med. 181:515-525.
15. Taki, S., M. Meiering, and K. Rajewsky. 1993. Targeted insertion of a variable region gene into the immunoglobulin heavy chain locus. Science. 262:1268-1271.
16. Lyon, A., and C. Parish. 1994. Determination of lymphocyte division by flow cytometry. J. Immunol. Methods. 171:131-137.
17. Enari, M., H. Sakahira, H. Yokoyama, K. Okawa, A. Iwamatsu, and S. Nagata. 1998. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature. 391:43-50.
18. Liu, X., H. Zou, C. Slaughter, and X. Wang. 1997. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell. 89:175-184.
19. Xiang, J., D.T. Chao, and S.J. Korsmeyer. 1996. BAX-induced cell death may not require interleukin 1 beta-converting enzyme-like proteases. Proc. Natl. Acad. Sci. USA. 93: 14559-14563.
20. McCarthy, N.J., M.K. Whyte, C.S. Gilbert, and G.I. Evan. 1997. Inhibition of Ced-3/ICE-related proteases does not prevent cell death induced by oncogenes, DNA damage, or the Bcl-2 homologue Bak. J. Cell Biol. 136:215-227.
21. Shimizu, S., A. Konishi, T. Kodama, and Y. Tsujimoto. 2000. BH4 domain of antiapoptotic Bcl-2 family members closes voltage-dependent anion channel and inhibits apoptotic mitochondrial changes and cell death. Proc. Natl. Acad. Sci. USA. 97:3100-3105.
22. Strasser, A., S. Whittingham, D.L. Vaux, M.L. Bath, J.M. Adams, S. Cory, and A.W. Harris. 1991. Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc. Natl. Acad. Sci. USA. 88: 8661-8665.
23. Budd, R.C. 2001. Activation-induced cell death. Curr. Opin. Immunol. 13:356-362.
24. Davidson, W.F., K.L. Holmes, J.B. Roths, and H.C. Morse, III. 1985. Immunologic abnormalities of mice bearing the gld mutation suggest a common pathway for murine nonmalignant lymphoproliferative disorders with autoimmunity. Proc. Natl. Acad. Sci. USA. 82:1219-1223.
25. Watanabe-Fukunaga, R., C.I. Brannan, N.G. Copeland, N.A. Jenkins, and S. Nagata. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature. 356:314-317.
26. Kroemer, G., and J.C. Reed. 2000. Mitochondrial control of cell death. Nat. Med. 6:513-519.
27. Ferri, K.F., and G. Kroemer. 2000. Control of apoptotic DNA degradation. Nat. Cell Biol. 2:E63-E64.
28. Berard, M., P. Mondiere, M. Casamayor-Palleja, A. Hennino, C. Bella, and T. Defrance. 1999. Mitochondria connects the antigen receptor to effector caspases during B cell receptor-induced apoptosis in normal human B cells. J. Immunol. 163:4655-4662.
29. Goodnow, C.C., J.G. Cyster, S.B. Hartley, S.E. Bell, M.P. Cooke, J.I. Healy, S. Akkaraju, J.C. Rathmell, S.L. Pogue, and K.P. Shokat. 1995. Self-tolerance checkpoints in B lymphocyte development. Adv. Immunol. 59:279-368.
30. Shokat, K.M., and C.C. Goodnow. 1995. Antigen-induced B-cell death and elimination during germinal-centre immune responses. Nature. 375:334-338.
31. Pulendran, B., G. Kannourakis, S. Nouri, K.G. Smith, and G.J. Nossal. 1995. Soluble antigen can cause enhanced apoptosis of germinal-centre B cells. Nature. 375:331-334.
32. Han, S., B. Zheng, J. Dal Porto, and G. Kelsoe. 1995. In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. IV. Affinity-dependent, antigen-driven B cell apoptosis in germinal centers as a mechanism for maintaining self-tolerance. J. Exp. Med. 182:1635-1644.
33. Murakami, M., T. Tsubata, M. Okamoto, A. Shimizu, S. Kumagai, H. Imura, and T. Honjo. 1992. Antigen-induced apoptotic death of Ly-1 B cells responsible for autoimmune disease in transgenic mice. Nature. 357:77-80.
34. Homburg, C.H., M. de Haas, A.E. von dem Borne, A.J. Verhoeven, C.P. Reutelingsperger, and D. Roos. 1995. Human neutrophils lose their surface Fc gamma RIII and acquire Annexin V binding sites during apoptosis in vitro. Blood. 85:532-540.
35. Peter, M.E., J. Dhein, A. Ehret, S. Hellbardt, H. Walczak, G. Moldenhauer, and P.H. Krammer. 1995. APO-1 (CD95)-dependent and -independent antigen receptor-induced apoptosis in human T and B cell lines. Int. Immunol. 7:1873-1877.
36. An, S., and K.A. Knox. 1996. Ligation of CD40 rescues Ramos-Burkitt lymphoma B cells from calcium ionophore- and antigen receptor-triggered apoptosis by inhibiting activation of the cysteine protease CPP32/Yama and cleavage of its substrate PARP. FEBS Lett. 386:115-122.
37. Falk, M.H., B.C. Trauth, K.M. Debatin, C. Klas, C.D. Gregory, A.B. Rickinson, A. Calender, G.M. Lenoir, J.W. Ellwart, P.H. Krammer, et al. 1992. Expression of the APO-1 antigen in Burkitt lymphoma cell lines correlates with a shift towards a lymphoblastoid phenotype. Blood. 79:3300-3306.
38. Lens, S.M., B.F. den Drijver, A.J. Potgens, K. Tesselaar, M.H. van Oers, and R.A. van Lier. 1998. Dissection of pathways leading to antigen receptor-induced and Fas/CD95-induced apoptosis in human B cells. J. Immunol. 160:6083-6092.
39. Bouchon, A., P.H. Krammer, and H. Walczak. 2000. Critical role for mitochondria in B cell receptor-mediated apoptosis. Eur. J. Immunol. 30:69-77.
40. Rickers, A., E. Brockstedt, M.Y. Mapara, A. Otto, B. Dorken, and K. Bommert. 1998. Inhibition of CPP32 blocks surface IgM-mediated apoptosis and D4-GDI cleavage in human BL60 Burkitt lymphoma cells. Eur. J. Immunol. 28:296-304.
41. Liu, Y.J., D.Y. Mason, G.D. Johnson, S. Abbot, C.D. Gregory, D.L. Hardie, J. Gordon, and I.C. MacLennan. 1991. Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis. Eur. J. Immunol. 21:1905-1910.
42. Pittner, B.T., and E.C. Snow. 1998. Strength of signal through BCR determines the fate of cycling B cells by regulating the expression of the Bcl-2 family of survival proteins. Cell. Immunol. 186:55-62.
43. Knox, K.A., M. Finney, A.E. Milner, C.D. Gregory, M.J. Wakelam, R.H. Michell, and J. Gordon. 1992. Second-messenger pathways involved in the regulation of survival in germinal-centre B cells and in Burkitt lymphoma lines. Int. J. Cancer. 52:959-966.
44. Ning, Z.Q., J.D. Norton, J. Li, and J.J. Murphy. 1997. Distinct mechanisms for rescue from apoptosis in Ramos human B cells by signalling through CD40 and interleukin-4 receptor: role for inhibition of an early response gene, Berg36. Biochem. Soc. Trans. 25:306S.
45. Lang, J., B. Arnold, G. Hammerling, A.W. Harris, S. Korsmeyer, D. Russell, A. Strasser, and D. Nemazee. 1997. Enforced Bcl-2 expression inhibits antigen-mediated clonal elimination of peripheral B cells in an antigen dose-dependent manner and promotes receptor editing in autoreactive, immature B cells. J. Exp. Med. 186:1513-1522.
46. Andjelic, S., and H.C. Liou. 1998. Antigen receptor-induced B lymphocyte apoptosis mediated via a protease of the caspase family. Eur. J. Immunol. 28:570-581.
47. Renno, T., A. Attinger, S. Locatelli, T. Bakker, S. Vacheron, and H.R. MacDonald. 1999. Cutting edge: apoptosis of superantigen-activated T cells occurs preferentially after a discrete number of cell divisions in vivo. J. Immunol. 162:6312-6315.
48. Dhein, J., H. Walczak, C. Baumler, K.M. Debatin, and P.H. Krammer. 1995. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature. 373:438-441.
49. Rothstein, T.L., J.K. Wang, D.J. Panka, L.C. Foote, Z. Wang, B. Stanger, H. Cui, S.T. Ju, and A. Marshak-Rothstein. 1995. Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature. 374:163-165.
50. Morris, S.C., N.L. Dragula, and F.D. Finkelman. 2002. IL-4 promotes Stat6-dependent survival of autoreactive B cells in vivo without inducing autoantibody production. J. Immunol. 169:1696-1704.
51. Bretscher, P., and M. Cohn. 1970. A theory of self-nonself discrimination: paralysis and induction involve the recognition of one or two determinants on antigen, respectively. Science. 163:1042-1049.
52. Mongini, P.K., Q. Liu, M.A. Vilensky, P.F. Highet, and J.K. Inman. 1998. Evidence for an upper affinity threshold for anti-IgM-induced apoptosis in a human B-cell lymphoma. Blood. 92:3756-3771.
53. Matsuuchi, L., and M.R. Gold. 2001. New views of BCR structure and organization. Curr. Opin. Immunol. 13:270-277.
54. Das, C., and J.J. Langone. 1987. Correlation between antitumor activity of protein A and in vivo formation of defined high molecular weight complexes with immunoglobulin G in BALB/c mice. Cancer Res. 47:2002-2007.
55. Kristiansen, S.V., V. Pascual, and P.E. Lipsky. 1994. Staphylococcal protein A induces biased production of Ig by VH3-expressing B lymphocytes. J. Immunol. 153:2974-2984.
56. Kozlowski, L.M., S.R. Kunning, Y. Zheng, L.M. Wheatley, and A.I. Levinson. 1995. Staphylococcus aureus Cowan I-induced human immunoglobin responses: preferential IgM rheumatoid factor production and VH3 mRNA expression by protein A-binding B cells. J. Clin. Immunol. 15:145-151.
57. Tutt, A.L., R.R. French, T.M. Illidge, J. Honeychurch, H.M. McBride, C.A. Penfold, D.T. Fearon, R.M. Parkhouse, G.G. Klaus, and M.J. Glennie. 1998. Monoclonal antibody therapy of B cell lymphoma: signaling activity on tumor cells appears more important than recruitment of effectors. J. Immunol. 161:3176-3185.
58. Parry, S.L., J. Hasbold, M. Holman, and G.G. Klaus. 1994. Hypercross-linking surface IgM or IgD receptors on mature B cells induces apoptosis that is reversed by costimulation with IL-4 and anti-CD40. J. Immunol. 152:2821-2829.
59. Kozono, Y., B.L. Kotzin, and V.M. Holers. 1996. Resting B cells from New Zealand Black mice demonstrate a defect in apoptosis induction following surface IgM ligation. J. Immunol. 156:4498-4503.
60. Parry, S.L., M.J. Holman, J. Hasbold, and G.G. Klaus. 1994. Plastic-immobilized anti-mu or anti-delta antibodies induce apoptosis in mature murine B lymphocytes. Eur. J. Immunol. 24:974-979.
61. Green, D.R., and D.W. Scott. 1994. Activation-induced apoptosis in lymphocytes. Curr. Opin. Immunol. 6:476-487.
62. Lawton, A.R., and M.D. Cooper. 1974. Modification of B lymphocyte differentiation by anti-immunoglobulins. Contemp. Top. Immunobiol. 3:193-225.
63. Kohler, H., D.R. Kaplan, and D.S. Strayer. 1974. Clonal depletion in neonatal tolerance. Science. 186:643-644.
64. Dintzis, H.M., R.Z. Dintzis, and B. Vogelstein. 1976. Molecular determinants of immunogenicity: the immunon model of immune response. Proc. Natl. Acad. Sci. USA. 73: 3671-3675.
65. Silverman, G.J., and C.S. Goodyear. 2001. In vivo VH targeted B-cell apoptotic deletion in mice and non-human primates. FASEBJ. 15:A694.
66. Parish, C.R., and H.S. Warren. 2001. Use of the intracellular fluorescent dye CFSE to monitor lymphocyte migration and proliferation. In Current Protocols in Immunology. J.E. Coligan, editor. John Wiley & Sons, Inc., New York. 4.9.1-4.9.8.